BIORESTORATIVE THERAPIES INC. - COMMON STOCK

BioRestorative to Participate in Benzinga All-Access Show Today to Discuss Compelling BRTX-100 Clinical Data, Leadership Enhancements and Strategic updates

18 июн 2025 06:35:00 Источник Nasdaq GlobeNewswire

BioRestorative Announces Share Repurchase Program

17 июн 2025 06:25:00 Источник Nasdaq GlobeNewswire

BioRestorative Reports Compelling Preliminary Data for FDA-Fast-Tracked BRTX-100 – an Autologous Stem Cell Therapy to Treat Chronic Lumbar Disc Disease

13 июн 2025 04:45:00 Источник Nasdaq GlobeNewswire

BioRestorative Welcomes Serial Regenerative Medicine Entrepreneur, Company Builder and Leader, Sandy Lipkins, to BRTX Team

10 июн 2025 05:00:00 Источник Nasdaq GlobeNewswire

BioRestorative to Present Major Update on Promising Preliminary Phase 2 BRTX-100 Data at ISSCR 2025

09 июн 2025 04:45:00 Источник Nasdaq GlobeNewswire

BioRestorative Therapies Reports First Quarter 2025 Financial Results and Provides Business Update

14 май 2025 13:05:00 Источник Nasdaq GlobeNewswire

Phase 2 Trial of BRTX-100 in cLDD Continues to Generate Positive Preliminary Blinded Data

13 май 2025 06:15:00 Источник Nasdaq GlobeNewswire

BioRestorative Therapies to Report First Quarter 2025 Financial Results and Host Conference Call on May 14, 2025

08 май 2025 13:30:00 Источник Nasdaq GlobeNewswire

BioRestorative to Present a BRTX-100 Clinical Update at ISCT 2025

07 май 2025 06:15:00 Источник Nasdaq GlobeNewswire

BioRestorative to Participate in Benzinga All-Access Show Today to Discuss Recent Achievements of Key Clinical & Regulatory Milestones, and Highlight Commercial Opportunities

15 апр 2025 05:30:00 Источник Nasdaq GlobeNewswire

BioRestorative Confirms No Material Impact from Reciprocal Tariffs; All BRTX-100 Production & Manufacturing Performed in the United States

10 апр 2025 06:15:00 Источник Nasdaq GlobeNewswire

BioRestorative Therapies Reports 2024 Financial Results and Provides Business Update

27 мар 2025 13:05:00 Источник Nasdaq GlobeNewswire

BioRestorative Therapies to Report 2024 Financial Results and Host Conference Call on March 27, 2025

20 мар 2025 13:30:00 Источник Nasdaq GlobeNewswire

BioRestorative Announces FDA Clearance of IND for Phase 2 Trial of BRTX-100 in Chronic Cervical Discogenic Pain

27 фев 2025 06:45:00 Источник Nasdaq GlobeNewswire

BioRestorative Announces Updated Time for February 27th Webcasted Conference Call to Discuss Clinical Pipeline Update

26 фев 2025 17:15:00 Источник Nasdaq GlobeNewswire

BioRestorative to Provide a Positive FDA Update on Clinical Pipeline

25 фев 2025 05:00:01 Источник Nasdaq GlobeNewswire

BioRestorative Receives FDA Fast Track Designation for BRTX-100 Chronic Lumbar Disc Disease Program

20 фев 2025 05:30:00 Источник Nasdaq GlobeNewswire

BRTX-100 Front and Center at ORS 2025

10 фев 2025 04:00:00 Источник Nasdaq GlobeNewswire

BioRestorative Therapies Announces Notice of Allowance of Key New Patent Protecting ThermoStem® Metabolic Disease Program

05 дек 2024 03:45:00 Источник Nasdaq GlobeNewswire

BioRestorative Therapies Reports Positive Preliminary Phase 2 BRTX-100 Clinical Data

13 ноя 2024 04:00:00 Источник Nasdaq GlobeNewswire